Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Andreas Meisel, Francesco Saccà, Jennifer Spillane, John Vissing |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
por: Nils Erik Gilhus, et al.
Publicado: (2024)
por: Nils Erik Gilhus, et al.
Publicado: (2024)
Economic and societal burden of myasthenia gravis in Denmark, Finland, and Sweden: A population‐based registry study
por: Fredrik Piehl, et al.
Publicado: (2024)
por: Fredrik Piehl, et al.
Publicado: (2024)
Intensive care due to myasthenia gravis: Risk factors and prognosis
por: Chris Myllynen, et al.
Publicado: (2024)
por: Chris Myllynen, et al.
Publicado: (2024)
Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis
por: David Reyes‐Leiva, et al.
Publicado: (2024)
por: David Reyes‐Leiva, et al.
Publicado: (2024)
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis
por: Jian Yin, et al.
Publicado: (2024)
por: Jian Yin, et al.
Publicado: (2024)
Efgartigimod in generalized myasthenia gravis: A real‐life experience at a national reference center
por: Rita Frangiamore, et al.
Publicado: (2024)
por: Rita Frangiamore, et al.
Publicado: (2024)
Tracking myasthenia gravis severity over time: Insights from the French health insurance claims database
por: Shahram Attarian, et al.
Publicado: (2024)
por: Shahram Attarian, et al.
Publicado: (2024)
Contractile properties and magnetic resonance imaging‐assessed fat replacement of muscles in myotonia congenita
por: Laura Nørager Jacobsen, et al.
Publicado: (2024)
por: Laura Nørager Jacobsen, et al.
Publicado: (2024)
Start, switch and stop (triple‐S) criteria for enzyme replacement therapy of late‐onset Pompe disease: European Pompe Consortium recommendation update 2024
por: Benedikt Schoser, et al.
Publicado: (2024)
por: Benedikt Schoser, et al.
Publicado: (2024)
Management of seizures in patients with primary mitochondrial diseases: consensus statement from the InterERNs Mitochondrial Working Group
por: Michelangelo Mancuso, et al.
Publicado: (2024)
por: Michelangelo Mancuso, et al.
Publicado: (2024)
Multiorgan Involvement and Mortality in Individuals With Adult‐Onset Myotonic Dystrophy (DM1)—A Danish Register‐Based Study I
por: Ulla Werlauff, et al.
Publicado: (2025)
por: Ulla Werlauff, et al.
Publicado: (2025)
Societal Costs, Healthcare Utilisation and Labour Market Affiliation of Persons With Adult‐Onset Myotonic Dystrophy Type 1 (DM1)—A Register‐Based Study II
por: Charlotte Handberg, et al.
Publicado: (2025)
por: Charlotte Handberg, et al.
Publicado: (2025)
Improvement in Patient‐Reported Symptoms of Generalised Myasthenia Gravis With Rozanolixizumab in the Randomised Phase 3 MycarinG Study Using the MG Symptoms PRO
por: Henry J. Kaminski, et al.
Publicado: (2025)
por: Henry J. Kaminski, et al.
Publicado: (2025)
Long‐Term Efficacy and Safety of Ravulizumab in Adults With Anti‐Acetylcholine Receptor Antibody‐Positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open‐Label Extension
por: Tuan H. Vu, et al.
Publicado: (2025)
por: Tuan H. Vu, et al.
Publicado: (2025)
Establishing how much improvement in lung function and distance walked is clinically important for adult patients with Pompe disease
por: Aglina Lika, et al.
Publicado: (2024)
por: Aglina Lika, et al.
Publicado: (2024)
Robotic Extended Thymectomy in Late‐Onset Myasthenia Gravis: A 21‐Year Retrospective Cohort Study of 172 Patients
por: Luyu Huang, et al.
Publicado: (2025)
por: Luyu Huang, et al.
Publicado: (2025)
Correction to “Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases ( ERN ‐ RND )”
Publicado: (2025)
Publicado: (2025)
Brief international cognitive assessment for MS (BICAMS) and NEDA maintenance in MS patients: A 2‐year follow‐up longitudinal study
por: E. Leveraro, et al.
Publicado: (2024)
por: E. Leveraro, et al.
Publicado: (2024)
Acute ischaemic stroke in active cancer versus non‐cancer patients: stroke characteristics, mechanisms and clinical outcomes
por: Gianluca Costamagna, et al.
Publicado: (2024)
por: Gianluca Costamagna, et al.
Publicado: (2024)
An assistive listening device improves hearing following aneurysmal subarachnoid haemorrhage
por: Ben Gaastra, et al.
Publicado: (2024)
por: Ben Gaastra, et al.
Publicado: (2024)
Two decades of patient advocacy
por: Mary Baker, et al.
Publicado: (2024)
por: Mary Baker, et al.
Publicado: (2024)
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database
por: Pietro Emiliano Doneddu, et al.
Publicado: (2024)
por: Pietro Emiliano Doneddu, et al.
Publicado: (2024)
Lyme neuroborreliosis in Japan: Borrelia burgdorferi sensu lato as a cause of meningitis of previously undetermined etiology in hospitalized patients outside of the island of Hokkaido, 2010–2021
por: Masayuki Ohira, et al.
Publicado: (2025)
por: Masayuki Ohira, et al.
Publicado: (2025)
Neurological autoimmunity in patients with non‐pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles
por: Georgios Mangioris, et al.
Publicado: (2024)
por: Georgios Mangioris, et al.
Publicado: (2024)
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study
por: Giorgia Coratti, et al.
Publicado: (2024)
por: Giorgia Coratti, et al.
Publicado: (2024)
Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia: A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC‐FTD)
por: Dirk van Paassen, et al.
Publicado: (2024)
por: Dirk van Paassen, et al.
Publicado: (2024)
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome
por: Gabriel Bsteh, et al.
Publicado: (2024)
por: Gabriel Bsteh, et al.
Publicado: (2024)
Criminality in patients with autoimmune encephalitis: A case series
por: Sophia Michael, et al.
Publicado: (2024)
por: Sophia Michael, et al.
Publicado: (2024)
Hypoalbuminemia in status epilepticus is a biomarker of short‐ and long‐term mortality: A 9‐year cohort study
por: Francesco Misirocchi, et al.
Publicado: (2024)
por: Francesco Misirocchi, et al.
Publicado: (2024)
Pelvic autonomic dysfunction is common in patients with pure autonomic failure
por: E. Vichayanrat, et al.
Publicado: (2024)
por: E. Vichayanrat, et al.
Publicado: (2024)
Peripheral Nerve Involvement in Friedreich's Ataxia Characterized by Quantitative Magnetic Resonance Neurography
por: Heike Jacobi, et al.
Publicado: (2025)
por: Heike Jacobi, et al.
Publicado: (2025)
Service delivery in acute ischemic stroke patients: Does sex matter?
por: Friedrich Medlin, et al.
Publicado: (2024)
por: Friedrich Medlin, et al.
Publicado: (2024)
Glymphatic system dysfunction and risk of clinical milestones in patients with Parkinson disease
por: Cheng Zhou, et al.
Publicado: (2024)
por: Cheng Zhou, et al.
Publicado: (2024)
An interdisciplinary integrated specialized one‐stop outpatient clinic for idiopathic intracranial hypertension—a comprehensive assessment of clinical outcome
por: Gabriel Bsteh, et al.
Publicado: (2024)
por: Gabriel Bsteh, et al.
Publicado: (2024)
Beyond early motor response: Longitudinal cognitive and gait assessments after extended lumbar drainage in normal pressure hydrocephalus
por: Stefano Caneva, et al.
Publicado: (2025)
por: Stefano Caneva, et al.
Publicado: (2025)
Clot signature in patients with large vessel occlusion stroke and concomitant active cancer
por: Malin Woock, et al.
Publicado: (2025)
por: Malin Woock, et al.
Publicado: (2025)
Clinical Findings in Temporal Lobe Epilepsy Associated With Isolated Amygdala Enlargement
por: Annika Kirscht, et al.
Publicado: (2025)
por: Annika Kirscht, et al.
Publicado: (2025)
Risk of Parkinson disease in stroke patients: A nationwide cohort study in South Korea
por: Hea Lim Choi, et al.
Publicado: (2024)
por: Hea Lim Choi, et al.
Publicado: (2024)
Atrial fibrillation in young stroke patients: Associated factors and outcomes in a nationwide analysis
por: Tania Garrido‐Hernández, et al.
Publicado: (2024)
por: Tania Garrido‐Hernández, et al.
Publicado: (2024)
Etiological distribution of isolated oculomotor nerve palsy: analysis of 633 patients and literature review
por: Hyun‐Jae Kim, et al.
Publicado: (2024)
por: Hyun‐Jae Kim, et al.
Publicado: (2024)
Ejemplares similares
-
Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
por: Nils Erik Gilhus, et al.
Publicado: (2024) -
Economic and societal burden of myasthenia gravis in Denmark, Finland, and Sweden: A population‐based registry study
por: Fredrik Piehl, et al.
Publicado: (2024) -
Intensive care due to myasthenia gravis: Risk factors and prognosis
por: Chris Myllynen, et al.
Publicado: (2024) -
Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis
por: David Reyes‐Leiva, et al.
Publicado: (2024) -
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis
por: Jian Yin, et al.
Publicado: (2024)